Privium Fund Management B.V. Wave Life Sciences Ltd. Transaction History
Privium Fund Management B.V.
- $551 Million
- Q3 2025
A detailed history of Privium Fund Management B.V. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Privium Fund Management B.V. holds 170,000 shares of WVE stock, worth $1.17 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
170,000
Previous 135,550
25.41%
Holding current value
$1.17 Million
Previous $881,000
39.05%
% of portfolio
0.22%
Previous 0.19%
Shares
5 transactions
Others Institutions Holding WVE
# of Institutions
217Shares Held
134MCall Options Held
1.22MPut Options Held
616K-
Ra Capital Management, L.P. Boston, MA18.2MShares$126 Million2.25% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA14.6MShares$101 Million0.18% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.39MShares$58 Million0.89% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$46.6 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.3MShares$43.5 Million0.38% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $600M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...